Sheikh Usman Iqbal

918 total citations
31 papers, 677 citations indexed

About

Sheikh Usman Iqbal is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sheikh Usman Iqbal has authored 31 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sheikh Usman Iqbal's work include Colorectal Cancer Treatments and Studies (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Sheikh Usman Iqbal is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Sheikh Usman Iqbal collaborates with scholars based in United States, United Kingdom and France. Sheikh Usman Iqbal's co-authors include Ruben A. Mesa, Hongwei Wang, Jyotsna Mehta, David Macarios, Lewis E. Kazis, Enkhe Badamgarav, Rachel Halpern, Susan D. Ross, Kerry Gairy and Ethel S. Siris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Sheikh Usman Iqbal

30 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheikh Usman Iqbal United States 12 204 176 165 159 157 31 677
Shangyi Jin China 11 35 0.2× 47 0.3× 61 0.4× 65 0.4× 34 0.2× 23 472
Debajyoti Bhowmik United States 13 27 0.1× 227 1.3× 49 0.3× 26 0.2× 57 0.4× 31 414
Aditya Raju United States 14 60 0.3× 137 0.8× 156 0.9× 5 0.0× 301 1.9× 41 756
Anju Parthan United States 11 12 0.1× 129 0.7× 63 0.4× 119 0.7× 113 0.7× 38 469
Rebecca Manno United States 14 142 0.7× 322 1.8× 102 0.6× 52 0.3× 85 0.5× 34 984
Tatyana Ionova Russia 10 54 0.3× 200 1.1× 37 0.2× 6 0.0× 54 0.3× 90 469
Laura Scaramucci Italy 15 117 0.6× 184 1.0× 33 0.2× 8 0.1× 64 0.4× 48 585
Koen Van Eygen Belgium 15 416 2.0× 210 1.2× 42 0.3× 4 0.0× 96 0.6× 51 1.0k
Margaret Telfer United States 12 255 1.3× 17 0.1× 58 0.4× 12 0.1× 117 0.7× 28 666
Sahrish Shah United States 14 108 0.5× 26 0.1× 89 0.5× 6 0.0× 153 1.0× 29 692

Countries citing papers authored by Sheikh Usman Iqbal

Since Specialization
Citations

This map shows the geographic impact of Sheikh Usman Iqbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheikh Usman Iqbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheikh Usman Iqbal more than expected).

Fields of papers citing papers by Sheikh Usman Iqbal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheikh Usman Iqbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheikh Usman Iqbal. The network helps show where Sheikh Usman Iqbal may publish in the future.

Co-authorship network of co-authors of Sheikh Usman Iqbal

This figure shows the co-authorship network connecting the top 25 collaborators of Sheikh Usman Iqbal. A scholar is included among the top collaborators of Sheikh Usman Iqbal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheikh Usman Iqbal. Sheikh Usman Iqbal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elimova, Elena, Jaffer A. Ajani, Sheikh Usman Iqbal, et al.. (2024). 1423P Zanidatamab + chemotherapy for first-line (1L) treatment of HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma (mGEA): New and updated data from a phase II trial. Annals of Oncology. 35. S887–S888. 4 indexed citations
2.
Spitzer, Andrew I., et al.. (2024). Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus. The Journal of Arthroplasty. 39(9). S218–S223.e1.
3.
Oderda, Gary M., et al.. (2019). Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden. Journal of Pain & Palliative Care Pharmacotherapy. 33(3-4). 82–97. 46 indexed citations
4.
Ayad, Sabry, Ashish K. Khanna, Sheikh Usman Iqbal, & Neil Singla. (2019). Characterisation and monitoring of postoperative respiratory depression: current approaches and future considerations. British Journal of Anaesthesia. 123(3). 378–391. 43 indexed citations
5.
Iqbal, Sheikh Usman, Tehseen Salimi, John Dunlop, & L. Clark Paramore. (2016). The Early Engagement Model in Product Development: Linking “Proof of Concept” to “Proof of Medical Value”. Therapeutic Innovation & Regulatory Science. 50(5). 592–601. 4 indexed citations
6.
Mehta, Jyotsna, Hongwei Wang, Jon P. Fryzek, Sheikh Usman Iqbal, & Ruben A. Mesa. (2014). Health resource utilization and cost associated with myeloproliferative neoplasms in a large United States health plan. Leukemia & lymphoma. 55(10). 2368–2374. 23 indexed citations
7.
Jones, Stephen E., Laura Liao, Zhimin Xiao, et al.. (2014). Resource utilization in patients with breast cancer treated with generic versus branded docetaxel.. Journal of Clinical Oncology. 32(15_suppl). 1015–1015. 2 indexed citations
8.
9.
Knopf, Kevin, et al.. (2013). Survival outcomes in U.S. patients with metastatic colorectal cancer: A retrospective database analysis.. Journal of Clinical Oncology. 31(15_suppl). e14576–e14576. 1 indexed citations
10.
Mesa, Ruben A., Jörge E. Cortes, Francisco Cervantes, et al.. (2013). Symptom Burden and Health-Related Quality Of Life (HRQoL) In Patients With Myelofibrosis (MF) Treated With Fedratinib (SAR302503) In a Phase III Study (JAKARTA). Blood. 122(21). 4061–4061. 3 indexed citations
11.
Knopf, Kevin, et al.. (2013). Survival outcomes in U.S. patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 31(4_suppl). 559–559. 1 indexed citations
12.
Mehta, Jyotsna, Hongwei Wang, Sheikh Usman Iqbal, & Ruben A. Mesa. (2013). Epidemiology of myeloproliferative neoplasms in the United States. Leukemia & lymphoma. 55(3). 595–600. 172 indexed citations
13.
Proskorovsky, Irina, Carmen J. Allegra, Josep Tabernero, et al.. (2013). Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer. British Journal of Cancer. 109(7). 1735–1743. 32 indexed citations
14.
15.
Iqbal, Sheikh Usman, et al.. (2012). Current practices in 1st- (1L), 2nd- (2L), and 3rd-line (3L) treatment for metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 30(15_suppl). e14028–e14028. 1 indexed citations
16.
Xu, Yingxin, et al.. (2012). Burden of illness in second-line colorectal cancer: A systematic literature review.. Journal of Clinical Oncology. 30(15_suppl). e14061–e14061. 1 indexed citations
17.
Ross, Susan D., et al.. (2011). A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence. Value in Health. 14(4). 571–581. 87 indexed citations
18.
19.
Iqbal, Sheikh Usman, et al.. (2010). Cost of fractures commonly associated with osteoporosis in a managed-care population. Journal of Medical Economics. 13(2). 302–313. 29 indexed citations
20.
Iqbal, Sheikh Usman, et al.. (2005). Pharmacoeconomic Evaluation of Antidepressants. PharmacoEconomics. 23(6). 595–606. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shangyi Jin Breakdown of academic impact, for papers by Debajyoti Bhowmik Breakdown of academic impact, for papers by Aditya Raju Breakdown of academic impact, for papers by Anju Parthan Breakdown of academic impact, for papers by Rebecca Manno Breakdown of academic impact, for papers by Tatyana Ionova Breakdown of academic impact, for papers by Laura Scaramucci Breakdown of academic impact, for papers by Koen Van Eygen Breakdown of academic impact, for papers by Margaret Telfer Breakdown of academic impact, for papers by Sahrish Shah
Rankless by CCL
2026